Gateway Exposome Hub for Alzheimer's and related dementias

Gateway Exposome Coordinating Center (GECC) For AD/ADRD Research

NIH-funded research University of Southern California · NIH-11139481

This project builds a central hub to standardize and share information about life-course environmental and social factors that can affect Alzheimer's and related dementias.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Southern California NIH-funded
Lab location1 site (Los Angeles, UNITED STATES)
Project IDNIH-11139481 on NIH RePORTER

What this research studies

The team will bring together researchers, community groups, and experts to set priorities and agree on which environmental and social measures matter most for Alzheimer's risk, resilience, and disparities. They will create harmonized measures across six areas—physical environment, social environment, policies, community services, extreme weather events, and life experiences—and produce guidance and best practices for using those measures. The center will use and expand the Gateway to Global Aging Data platform to host, link, and share exposome data from different studies and cohorts. The goal is to make it easier for researchers to combine and compare data so findings about exposures and dementia are more reliable and useful.

Who could benefit from this research

Good fit: People most directly involved would include older adults with Alzheimer's or related dementias, people at risk, caregivers, and members of existing research cohorts who can share exposure and life-course information.

Not a fit: People seeking immediate treatments or direct clinical benefits are unlikely to receive personal benefit from this coordinating and data-harmonization effort.

Why it matters

Potential benefit: If successful, this could help researchers identify environmental and social factors that lead to better prevention strategies and fairer care for people with Alzheimer's and related dementias.

How similar studies have performed: Similar harmonization efforts like the Gateway to Global Aging Data have advanced aging research, but applying harmonized exposome measures specifically to Alzheimer's is a newer and still-developing approach.

Where this research is happening

Los Angeles, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.